From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening ...

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

Since its founding in 1998, Mission of Hope has provided more than 400 million meals, educated more than 163,000 students, provided medical treatment to more than 760,000 ... "These funds will help ...

frequently within the context of commercial sex work (Shankle 2006). Needle injection practices may also increase risk for HIV through unsafe injection of recreational drugs or substances to alter ...

But with the twice-yearly drug showing strong potential as a long-acting PrEP option, Gilead is looking to “redefine the PrEP market as a whole,” Chief Commercial Officer Johanna Mercier said ...

The Pakistan Stock Exchange (PSX) held a gong ceremony to celebrate the listing of BF Biosciences Limited (BFBIO). BFBIO is a ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...

Michael (name concealed for privacy reasons), 21, contracted syphilis in July 2024 through his partner. The partner, who is ...

The companies noted that, at 48 weeks, the novel investigational combination maintained a high rate (n=49; 94.2%) of viral ...

Gilead says the deal, made just weeks after clinical trial results showed how well the drug works, will provide rapid and broad access to a medication ... Gilead’s chief commercial officer.

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...